News

Background Medium vessel occlusions (MeVOs) account for 25–40% of acute ischemic stroke. The Tenzing 5 (Route 92 Medical, San Mateo, California, USA) and FreeClimb 54 (Route 92 Medical, San Mateo, ...
Overview of Plasmapheresis MarketThe Global Plasmapheresis Market is valued at USD 1.34 Billion in 2024 and is projected to ...
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today unveiled new real-world U.S. physician preference data for the SOFIA™ 88 ...
Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), today announced a new U.S. distribution agreement with Caretaker Medical to offer Caretaker Medical's VitalStream ...
Terumo Interventional Systems (TIS), a division of Terumo Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies.
Choosing the best options to buy telemedicine carts for neurology care depends on how the software helps neurologists and health care physicians assist patients with the highest quality care.
Neuro.io will invest $100 million for an innovation campus in Terrebonne Parish, LA, creating 1,100 jobs. (Photo: Linkedin/Louisiana Economic Development) ...
HOUMA, La. (press release) – Neuro.io, powered by global neurotechnology company MindMaze AI, announced its plans to establish a $100 million innovation campus in Terrebonne Parish. Known as BrainHUB, ...
Lyn Redwood, a former president of the anti-vaccine group founded by RFK Jr., Children’s Health Defense, gave a presentation to the ACIP Thursday morning blaming thimerosal for neurological issues.